Patents
Patents for C07D 223 - Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom (8,732)
07/2002
07/24/2002EP1102743B1 Amide derivatives which are useful as cytokine inhibitors
07/24/2002EP1015425B1 Caprolactam production process
07/18/2002WO2002055493A1 METHOD FOR STORING AND TRANSPORTING N-VINYL-ε-CAPROLACTAM
07/18/2002WO2002042250B1 DERIVATIVES OF 4-HYDROXYBUTANOIC ACID AND OF ITS HIGHER HOMOLOGUE AS LIGANDS OF η-HYDROXYBUTYRATE (GHB) RECEPTORS, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AND PHARMACEUTICAL USES
07/17/2002EP1223161A2 Method to stabilise and/or lower the color number of alkenyl compounds
07/17/2002CN1087738C Method for purifying 5H-dipheyl [6,f] azepine
07/16/2002US6420395 Disorders or diseases involving the cholinergic system of the central nervous system, pain, inflammatory diseases, diseases caused by smooth muscle contractions and as assistance in the cessation of chemical substance abuse.
07/16/2002US6420363 Mono- or polyenic carboxylic acid derivatives
07/16/2002CA2206172C New derivatives of 10,11-dihydro-10-oxo-5h-dibenz/b,f/azepine-5-carboxamide
07/11/2002WO2002053516A2 N(phenylsulphonyl)glycine derivatives and their therapeutic use
07/11/2002WO2002026750A3 Phosphino-aminophosphines, catalyst complexes and enantioselective hydrogenation
07/11/2002WO2002026705A3 Highly enantiomerically pure lactam-substituted propanoic acid derivatives and their preparation
07/11/2002US20020091255 Where the caprolactam is kept in the liquid phase
07/11/2002US20020091254 Stabilizing and/or lowering the color number of alkenyl compounds
07/11/2002DE10100752A1 Verfahren zur Lagerung und Transport von N-Vinyl-epsilon-caprolactam A method of storing and transporting N-vinyl-epsilon-caprolactam
07/11/2002DE10100751A1 Verfahren zur Stabilisierung und/oder Senkung der Farbzahl von Alkenylverbindungen A method for stabilizing and / or reducing the color number of alkenyl
07/11/2002CA2434124A1 N(phenylsulphonyl)glycine derivatives and their therapeutic use
07/10/2002EP1221441A2 LTA4 Hydrolase inhibitors
07/10/2002EP1221440A1 Benzoheterocyclic derivatives useful as vasopressin or oxytocin modulators
07/09/2002US6417161 Amino acid amidinohydrazones, alkoxyguanidines and aminoguanidines as protease inhibitors
07/04/2002WO2002051983A2 Novel compounds and compositions as cathepsin inhibitors
07/04/2002WO2002051838A1 Novel benzazepines and related heterocyclic derivatives which are useful as orexin receptor antagonists
07/04/2002WO2002051824A1 Amidinophenylalanine derivatives as thrombin inhibitors
07/04/2002WO2002051813A2 PROCESS FOR THE PREPARATION OF α-AMINOSUBSTITUTED CARBOXYLIC ACID AMIDES
07/04/2002WO2002051232A2 Novel benzazepines and related heterocyclic derivatives
07/04/2002US20020086995 Recrystallizing mercaptoalkanoylamino lactam acid under basic conditions using an agent that minimizes amount of disulfides
07/04/2002US20020086994 Deprotection processes
07/04/2002CA2668823A1 Process for the preparation of .alpha.-aminosubstituted carboxylic acid amides
07/04/2002CA2433520A1 Novel compounds and compositions as cathepsin inhibitors
07/04/2002CA2433089A1 Process for the preparation of .alpha.-aminosubstituted carboxylic acid amides
07/03/2002EP0793650B1 Method of producing caprolactam
07/03/2002EP0563345B1 Novel 4-arylpiperazines and 4-arylpiperidines
07/02/2002USRE37781 Substituted cyclic carbonyls and derivatives thereof useful as retroviral protease inhibitors
07/02/2002US6413954 Certain substituted caprolactam carbonates and ethers, pharmaceutical compositions containing them and their use in treating tumors
07/02/2002US6413947 Antiinflammatory agents; rheumatic diseases; anticholesterol agents
07/02/2002US6413657 Benzoazepine derivative polymers as luminescent element materials
06/2002
06/27/2002WO2002050026A1 Process for synthesizing lactam
06/27/2002WO2002049646A1 Therapeutic combination of amlodipine and benazepril/benazeprilat
06/27/2002WO2002049645A1 Therapeutic combination of amlodipine and benazepril
06/27/2002WO2001095856A3 Urea derivative useful as an anti-cancer agent and process for preparing same
06/27/2002WO2001049665A3 Method for purifying lactames
06/27/2002CA2432638A1 Therapeutic combination of amlodipine and benazepril
06/27/2002CA2432282A1 Therapeutic combination of amlodipine and benazepril/benazeprilat
06/26/2002EP1216230A2 Fused cycloheptane and fused azacycloheptane compounds and their use as integrin receptor antagonists
06/25/2002US6410527 Method of treating obsessive compulsive disorders, somatoform disorders, dissociative disorders, eating disorders, impulse control disorders, and autism
06/25/2002US6410526 Bone disorders; restenosis; vision disorders; anticholesterol agents; anticancer, antitumor agents
06/20/2002WO2002048099A1 Carboxylic acid amide derivatives and their use in the treatment of thromboembolic diseases and tumours
06/20/2002WO2002047679A2 Nonpeptide agonists and antagonists of vasopressin receptors
06/20/2002WO2002047671A2 Lactam compound to inhibit beta-amyloid peptide release or synthesis
06/20/2002DE10063008A1 Carbonsäureamidderivate Carboxamide
06/20/2002CA2432825A1 Nonpeptide agonists and antagonists of vasopressin receptors
06/20/2002CA2431766A1 Carboxymide derivatives and their use in the treatment of thromboembolic diseases and tumours
06/19/2002CN1354172A Method for removing nitrous acid gas
06/18/2002US6407229 Enzyme inhibitor
06/12/2002EP1212306A2 Hydroxyalkanoylaminolactams and related structures as inhibitors of abeta protein production
06/12/2002EP0934080B1 1,3-bis-(n-lactamyl) propane and the pharmaceutical and cosmetic use thereof
06/11/2002US6403578 Anticoagulants, cardiovascular disorders
06/11/2002US6403577 Hexamethyleneiminyl tachykinin receptor antagonists
06/06/2002WO2002044246A1 Modified polylactam
06/06/2002WO2002043713A2 Use of weak opioids and mixed opioid agonists/antagonists for treating urinary incontinence
06/06/2002US20020068741 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds
06/06/2002DE10059415A1 Verwendung von schwachen Opioiden und gemischten Opioidagonisten/-antagonisten zur Therapie der Harninkontinenz Use of weak opioids and mixed opioid agonist / antagonist for the treatment of urinary incontinence
06/05/2002EP1211275A1 Modified Polylactam
06/05/2002EP1211239A1 Process for the preparation of 2,3-dihydroazepine compounds
06/05/2002EP1210332A1 Bleach boosting components, compositions and laundry methods
06/05/2002CN1085980C Meta-guanidine, urea, thiourea or azacyclic amino benzoic and derivatives as integrin antagaonists
06/04/2002US6399771 Cyclic imines as pesticides
05/2002
05/30/2002WO2002042273A2 Acid derivatives useful as serine protease inhibitors
05/30/2002WO2002042257A1 Substituted cyclohexane derivates and the use thereof in medicaments for treating cardiovascular diseases
05/30/2002WO2002042250A1 DERIVATIVES OF 4-HYDROXYBUTANOIC ACID AND OF ITS HIGHER HOMOLOGUE AS LIGANDS OF η-HYDROXYBUTYRATE (GHB) RECEPTORS, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AND PHARMACEUTICAL USES
05/30/2002WO2002020526A3 Cyclic and acyclic amidines and pharmaceutical compositions containing them for use as progesterone receptor binding agents
05/30/2002US20020065417 Useful as ligands for metal catalysts for asymmetric reactions, in particular as rhodium complexes for asymmetric hydrogenation of enamide, itaconate, and alpha-ketoester compounds
05/30/2002US20020065414 Quarternary ammonium salt can act as phase-transfer catalyst to convert glycine derivatives into optically active alpha-amino acid derivatives by stereoselectively alkylating glycine derivatives
05/30/2002US20020065269 3-Sulfonylamino-c5 to c8-methyleneimino-2-carboxylic acid compound is effective for prophylaxis and treatment of inflammation, tissue degradation, cancer, fibrosis and related diseases
05/30/2002CA2429328A1 Substituted cyclohexane derivates and the use thereof in medicaments for treating cardiovascular diseases
05/30/2002CA2428191A1 Acid derivatives useful as serine protease inhibitors
05/29/2002CN1085667C Substituted tetracylic azepine derivatives having affinity for 5-HT2 receptors
05/23/2002WO2002040471A2 Tetrahydrobenzazepine derivatives useful as modulators of dopamine d3 receptors (antipsychotic agents)
05/23/2002WO2002040452A2 Production of alkyl 6-aminocaproate
05/23/2002WO2002040451A2 Lactam compound
05/23/2002WO2002040440A1 Production of 6-aminocaproic acid
05/23/2002WO2001074348A8 Vasopeptidase inhibitors to treat isolated systolic hypertension
05/23/2002WO2001072707A3 Carbamate caspase inhibitors and uses thereof
05/23/2002US20020061874 Substituted lactam; gamma-secretase inhibitor; decreases production of beta-amyloid; treatment for Altzheimer's and Down's syndrome
05/23/2002CA2428844A1 Tetrahydrobenzazepine derivatives useful as modulators of dopamine d3 receptors (antipsychotic agents)
05/23/2002CA2423319A1 Production of 6-aminocaproic acid
05/23/2002CA2423084A1 Production of alkyl 6-aminocaproate
05/22/2002EP1206411A1 Process for treating a mixture comprising an ammonium sulfate solution phase and an aqueous lactam phase
05/22/2002CN1350458A Protease inhibitors
05/16/2002WO2002037937A2 Acid derivatives useful as serine protease inhibitors
05/16/2002WO2001072697A3 Process for the carbonylation of pentenenitrile
05/16/2002DE10055653A1 Baeyer-Villger oxidation of aldehyde or ketone to give carboxylic acid or ester involves reaction with hydrogen peroxide in fluorinated alcohol solvent in presence of protic acid catalyst
05/16/2002CA2426716A1 Acid derivatives useful as serine protease inhibitors
05/15/2002CN1348956A Substituted diazacycloheptane compound, medicine composite contg. same and the use thereof
05/14/2002US6387544 OLEDS containing thermally stable glassy organic hole transporting materials
05/10/2002WO2002036555A1 Sulfamides as gamma-secretase inhibitors
05/09/2002US20020055503 Treatment of seizures resulting from, e.g. epileptic attack.
05/09/2002US20020055500 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting B-amyloid peptide release and/or its synthesis by use of such compounds
05/08/2002EP1202988A2 Novel integrin receptor antagonists
05/07/2002US6384217 Intermediates for production of carbamazepine and oxcarbamazepine
1 ... 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 ... 88